Keyword "PREECLAMPSIA" found in the following publications:

• NEW APPROACHES OF MORFOFUNKTIONAL PHARMACOLOGICAL CORRECTION OF VIOLATIONS OF CARDIOVASCULAR SYSTEM IN EXPERIMENTAL PREECLAMPSIA

  Experimental Modeling ADMA-like preeclampsia administration to rats was performed by N-nitro-L-arginine methyl ester, from 14 to 20 days of pregnancy. ...

  Abstract | Full text (PDF)

• FEATURES OF GENE CONTROL OF BLOOD PRESSURE IN PATIENTS WITH HYPERTENSIVE DISORDERS DURING PREGNANCY
   

  Background: Chronic arterial hypertension and preeclampsia are multifactorial pathologies, in the development of which many groups of genes are ...

  Abstract | Full text (PDF)

• EVOLUTIONARY-GENETIC ANALYSIS OF THE ROLE OF REGULATORY REGIONS IN CORO2A GENE IN THE DEVELOPMENT OF HEREDITARY PREDISPOSITION TO PREECLAMPSIA IN RUSSIAN AND YAKUT ETHNIC GROUPS

  Background: Preeclampsia (PE) is one of the most serious pregnancy complications and is the leading cause of maternal and ...

  Abstract | Full text (PDF)

• PRECLINICAL STUDY OF INNOVATIVE PEPTIDES MIMICKING THE SPACE STRUCTURE OF THE Α-HELIX B OF ERYTHROPOIETIN
   

  Introduction: The aim of this study was to examine the effectiveness of innovative peptides obtained by addition of polypeptide motifs ...

  Abstract | Full text (PDF)

• THE STATE OF MICROCIRCULATION IN PREGNANT WOMEN WITH HYPERTENSIVE DISORDERS IN THE THIRD TRIMESTER OF PREGNANCY
   

  Background: Hypertensive disorders during pregnancy remain the most significant problem of modern obstetrics, taking the main place in the ...

  Abstract | Full text (PDF)

• CORRECTION OF MORPHOFUNCTIONAL DISTURBANCES ARISING WHEN MODELLING PREECLAMPSIA WITH RESVERATROL AND NICORANDIL

  Introduction: Preeclampsia is one of the most serious diseases of the second half of pregnancy and is surely amongst ...

  Abstract | Full text (PDF)

• FEATURES OF THE COURSE OF CHILDBIRTH IN PREECLAMPSIA OF VARYING SEVERITY AT THE PRESENT STAGE
   

  Background: Identification of complications of childbirth in preeclampsia will enable to improve perinatal outcomes in this group of ...

  Abstract | Full text (PDF)

• RS34845949 POLYMORPHISM OF THE SASH1 GENE IS ASSOCIATED WITH THE RISK OF PREECLAMPSIA
   

  Background: Preeclampsia (PE) is a multisystem pathological condition that occurs in the second half of pregnancy (after the ...

  Abstract | Full text (PDF)

• CORRECTION OF ADMA-INDUCED PREECLAMPSIA WITH THE USE OF PHOSPHODIESTERASE 5 AND SELECTIVE INHIBITOR OF ARGINASE II ZB49-0010

  Simulation experimental ADMA-like preeclampsia was carried out by administering the rats with L-NAME during 14-20 days of pregnancy. In animals, ...

  Abstract | Full text (PDF)

• PHARMACOLOGICAL CORRECTION OF ENDOTHELIAL DYSFUNCTION USING ADEMETHIONIN AND TAURINE

  Introduction: Рharmacological correction of endothelial dysfunction is a urgent problem of modern medicine.

  Materials and methods: Endothelial dysfunction was simulated ...

  Abstract | Full text (PDF)

• THE EFFECT OF HUMORAL FACTORS RELEASED BY HYPOPERFUSED PLACENTA ON FETAL DEVELOPMENT

  Simulation of hypoperfusion of the right uterine horn in rats on the 14th day of pregnancy resulted in disruption of ...

  Abstract | Full text (PDF)

• POLYMORPHISM OF GENES ASSOCIATED WITH THE AGE AT MENARCHE AND THE RISK OF COMPLICATIONS OF PREGNANCY IN WOMEN IN THE CENTRAL BLACK EARTH REGION OF RUSSIA
   

  Background: The most common complications of pregnancy associated with metabolic and hemodynamic disorders in the mother-placenta-fetus system are ...

  Abstract | Full text (PDF)

• COMPREHENSIVE ASSESSMENT OF USING MICRONISED PURIFIED FLAVONOID FRACTION IN THE CORRECTION OF DISORDERS ASSOCIATED WITH ADMA-LIKE PREECLAMPSIA IN EXPERIMENT
   

  Background: About 10% of pregnancies in the world are accompanied by hypertensive disorders, while from 2 to 8% are preeclampsia. ...

  Abstract | Full text (PDF)

• CORRECTION OF MORPHOFUNCTIONAL DISORDERS OF THE CARDIOVASCULAR SYSTEM WITH ASIALIZED ERYTHROPOIETIN AND ARGINASE II SELECTIVE INHIBITORS KUD 974 AND KUD 259 IN EXPERIMENTAL PREECLAMPSIA
  
   

  Introduction: Preeclampsia remains one of the most common causes of maternal and perinatal mortality worldwide. A significant role in the ...

  Abstract | Full text (PDF)

• GENETIC MARKERS OF SEVERE PREECLAMPSIA

  Background: In modern medicine, close attention is paid to the issues of reducing maternal morbidity and mortality, to the ...

  Abstract | Full text (PDF)

• STUDY OF THE EFFECT OF SELECTIVE INHIBITOR OF ARGINASE II KUD 975 AND OF LOW DOSES OF ACETYLSALICYLIC ACID ON THE FUNCTIONAL PARAMETERS OF THE CARDIOVASCULAR SYSTEM IN EXPERIMENTAL PREECLAMPSIA

  Introduction: Over the past decade, preeclampsia has been the subject of an increased attention, as this complication is the most ...

  Abstract | Full text (PDF)

• L-NAME-INDUCED PREECLAMPSIA: CORRECTION OF FUNCTIONAL DISORDERS OF THE HEMOSTASIS SYSTEM WITH RESVERATROL AND NICORANDIL

  Introduction. Preeclampsia is a formidable disease of the second half of pregnancy, leading to severe complications, including disability and even death. ...

  Abstract | Full text (PDF)

• TERMS OF EMERGENCE OF THE MAIN CLINICAL SYMPTOMS OF PREECLAMPSIA AT THE PRESENT STAGE

  The purpose of the research was to study the terms of appearance of the first clinical symptoms of preeclampsia ...

  Abstract | Full text (PDF)

• THE EFFECT OF EARLY AND LATE PHARMACOLOGICAL CORRECTION WITH GABA DERIVATIVES OF PSYCHOEMOTIONAL STATE OF OFFSPRING OF RATS WITH EXPERIMENTAL PREECLAMPSIA
   

  Introduction: Preeclampsia is a serious complication of pregnancy, which increases the risk of anxiety disorders and depression in children at ...

  Abstract | Full text (PDF)